BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8905940)

  • 1. [Molecular biological study on structure and function of the opioid receptor].
    Fukuda K
    Masui; 1996 Sep; 45(9):1060-66. PubMed ID: 8905940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the structure and function of opioid receptors.
    Law PY; Wong YH; Loh HH
    Biopolymers; 1999; 51(6):440-55. PubMed ID: 10797232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition of opioid receptor ligands.
    Kane BE; Svensson B; Ferguson DM
    AAPS J; 2006 Mar; 8(1):E126-37. PubMed ID: 16584119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
    Chen Y; Mestek A; Liu J; Hurley JA; Yu L
    Mol Pharmacol; 1993 Jul; 44(1):8-12. PubMed ID: 8393525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors.
    Coward P; Chan SD; Wada HG; Humphries GM; Conklin BR
    Anal Biochem; 1999 Jun; 270(2):242-8. PubMed ID: 10334841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and regulation of opioid receptors.
    Chaturvedi K; Christoffers KH; Singh K; Howells RD
    Biopolymers; 2000; 55(4):334-46. PubMed ID: 11169924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa.
    Bradford CS; Walthers EA; Searcy BT; Moore FL
    J Mol Endocrinol; 2005 Jun; 34(3):809-23. PubMed ID: 15956349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementarity of delta opioid ligand pharmacophore and receptor models.
    Mosberg HI
    Biopolymers; 1999; 51(6):426-39. PubMed ID: 10797231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
    Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
    Ulens C; Van Boven M; Daenens P; Tytgat J
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant opioid receptors. Structure-function relationship.
    Filipovska J; Gomes I; Xu W; Chen C; Liu-Chen LY; Devi LA
    Methods Mol Med; 2003; 84():185-203. PubMed ID: 12703324
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application].
    Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):107-16. PubMed ID: 9866825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
    Lee JW; Joshi S; Chan JS; Wong YH
    J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
    Raynor K; Kong H; Chen Y; Yasuda K; Yu L; Bell GI; Reisine T
    Mol Pharmacol; 1994 Feb; 45(2):330-4. PubMed ID: 8114680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
    Simonin F; Befort K; Gavériaux-Ruff C; Matthes H; Nappey V; Lannes B; Micheletti G; Kieffer B
    Mol Pharmacol; 1994 Dec; 46(6):1015-21. PubMed ID: 7808419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type.
    Bunzow JR; Saez C; Mortrud M; Bouvier C; Williams JT; Low M; Grandy DK
    FEBS Lett; 1994 Jun; 347(2-3):284-8. PubMed ID: 8034019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering and functional immobilization of opioid receptors.
    Ott D; Neldner Y; Cèbe R; Dodevski I; Plückthun A
    Protein Eng Des Sel; 2005 Mar; 18(3):153-60. PubMed ID: 15790572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.